02.03.2020
Acino completes acquisition with Takeda for primary care portfolio in key emerging markets
Acino and Takeda Pharmaceuticals announced today the completion of the acquisition for parts of Takeda’s primary care portfolio in selected...
News
21.02.2020
Acino recognised as the Best Pharmaceutical Company 2019 in Armenia
Acino is proud to have been recognised as the Best Pharmaceutical Company 2019 by the Armenia Diaspora association in Armenia...
06.02.2020
Acino receives EU GMP certification in Ukraine
Acino’s manufacturing plant in Ukraine—Pharma Start—has successfully been certified according to the Good Manufacturing Practice of the European Union (EU...
20.12.2019
Merhaba Türkiye!
On December 18, Acino completed the registration of the company as a legal entity in Turkey, paving the way to...
19.12.2019
Acino featured in ‘Future of Pharmaceuticals’
Under the headline ‘Acino and Quay steer new course for contract development and manufacturing.’ our Contract Manufacturing team recently spoke to...
31.10.2019
Acino Contract Manufacturing agrees strategic partnership with Quay Pharma
Acino Contract Manufacturing is pleased to announce a strategic partnership with UK-based Quay Pharma for the formulation and development of...
15.10.2019
Acino signs agreement to acquire Takeda primary care portfolio in key emerging markets
Acino and Takeda Pharmaceuticals announced today that they have signed an agreement for Acino to acquire parts of Takeda’s primary...
19.09.2019
Announcement of Ralph Halter as New Global Head of IT
We are pleased to announce the appointment of Ralph Halter as the new Global Head of IT and a member...
20.08.2019
Appointment of Steve Mahoney as Head of Region (ESA, LATAM, Russia)
We are pleased to announce the appointment of Steve Mahoney as Head of Region – English-Speaking Africa, Latin America and...